Osteomyelitis: Symptoms, Diagnosis And Treatment

Sources checked on 9 October 2026. This guide explains the questions that arise when bone infection is suspected or treated, how different clinical situations change those questions, and ways to prepare for care.

Anatomical illustration of a person holding a knee highlighted in red — Original illustration of knee pain. A red highlight does not establish bone infection or its location. [3]

Osteomyelitis: Symptoms That Need Assessment

Osteomyelitis is an infection of bone that needs medical assessment and treatment. Pain, swelling, warmth and skin colour changes are possible signs; redness can be harder to see on darker skin. Fever may occur, but its absence is not reassuring enough to dismiss a problem. Seek prompt clinical assessment for these symptoms, feeling generally unwell, or symptoms returning after an earlier bone infection. A child who refuses to use an arm or leg, develops a limp or seems unusually irritable needs assessment even without fever. Early care can reduce the risk of lasting bone damage. [4]

When an Infection Becomes an Emergency

Sepsis is a dangerous whole-body response to an infection and is a medical emergency. With a suspected or known infection, new confusion, breathlessness, clammy skin, a weak pulse, or extreme pain and rapidly worsening illness require immediate emergency assessment. Someone may feel very cold or shivery rather than simply having a high temperature. Do not wait for every warning sign to appear or for a scheduled appointment. Tell emergency clinicians about any wound, recent operation or infection already being treated. Identifying an organism is useful, but tests must not postpone urgent evaluation and treatment of possible sepsis. [1]

How Injury and Surgery Change the Picture

Bone infection can follow an injury that gives bacteria access to deeper tissues, including an open fracture. Infection can also appear after fracture surgery or later in recovery. Increasing pain, warmth, swelling or wound drainage deserve review by the treating team, particularly when recovery has changed direction. Some inflammation accompanies normal healing, so appearance alone cannot settle the diagnosis. Open fractures themselves are surgical emergencies. When infection complicates fracture repair, both controlling infection and obtaining stable bone healing matter. Treatment may involve several procedures, and the recovery plan depends on the injury, tissues and overall health. [5]

Why a Foot Infection May Not Hurt Much

Diabetes can damage nerves, reducing the pain that would normally draw attention to a blister or cut. Reduced circulation can also make a wound harder to heal. These are different problems, and both deserve assessment when a foot wound develops. A small-looking wound or little pain does not reliably show what is happening underneath. Check feet regularly and seek prompt help for a new red, warm or swollen area, an infected-looking wound, or a wound that is worsening or not healing. The care team may include a foot specialist as well as clinicians managing diabetes and circulation. [6]

Back Pain and Native Vertebral Infection

Adult native vertebral osteomyelitis affects spinal bones without being a spinal implant infection. Persistent or worsening back or neck pain, especially with fever or a recent bloodstream infection, needs clinical attention. New weakness, loss of sensation or bladder or bowel dysfunction with back pain warrants emergency assessment. The IDSA guideline still listed as current is dated 2015. It supports blood cultures, neurological examination and MRI. In stable patients, clinicians may obtain diagnostic samples before antibiotics; sepsis, circulatory instability or progressive neurological problems require immediate treatment. This sampling decision belongs to the clinical team, never to patients stopping prescribed antibiotics. [2]

Children Need a Separate Assessment

Acute hematogenous osteomyelitis in children means infection that reaches bone through the bloodstream. Pediatric assessment considers the child’s age, examination, likely organisms and whether nearby joints or collections of infected fluid are involved. Staphylococcus aureus is important, but age and underlying conditions can change the possibilities. The PIDS/IDSA guideline remains dated 2021. It recommends blood cultures before treatment when feasible, and starting antibiotics immediately in an ill-looking child or a rapidly progressing infection. Sampling plans must not delay that care. Children with uncomplicated recovery and those with abscesses or other complications do not necessarily follow the same pathway. [7]

A Similar Name Can Describe a Different Disease

Chronic nonbacterial osteomyelitis, sometimes called chronic recurrent multifocal osteomyelitis, is an inflammatory bone disorder rather than a bacterial infection. It can involve one or several bones and cause recurring pain. This is different from a bacterial infection that persists or returns after treatment. Specialists establish the distinction by considering the whole presentation and excluding infection, cancer and other explanations; imaging and sometimes biopsy contribute. A negative culture alone should not become a self-diagnosis of nonbacterial disease. The similar terminology is a good reason to ask which condition a diagnosis actually describes before interpreting information about its treatment or outlook. [8]

What Imaging Can and Cannot Establish

Imaging is chosen for the suspected site and clinical question. For suspected peripheral bone infection, radiographs often provide the first assessment, although early infection may leave them normal. MRI can show marrow abnormalities, nearby soft tissues and collections that affect treatment planning. The American College of Radiology separates general peripheral infection guidance, revised in 2022, from diabetic-foot guidance, revised in 2025. MRI is usually the next study when diabetic-foot radiographs are inconclusive. CT or nuclear imaging may help in selected circumstances, including difficulties caused by metal. No scan directly identifies the responsible bacterium; imaging must be interpreted alongside other findings. [3]

Blood Tests Are Parts of the Evidence

Inflammatory blood tests measure the body’s response; they do not label a bone as infected. C-reactive protein and the erythrocyte sedimentation rate can support an investigation, while the white blood cell count may remain normal. Other inflammatory problems can raise these measurements. A European multidisciplinary consensus on adult peripheral bone infection therefore considers examination, blood tests, imaging and appropriately collected samples together. Blood cultures answer a different question: whether an organism can be recovered from the bloodstream. Their usefulness varies with how the infection reached the bone. Neither a normal result nor a single elevated value replaces clinical interpretation. [9]

A bedside test needs clinical context

Clinicians sometimes assess whether a foot ulcer reaches bone using a sterile probe. In Lavery and colleagues’ cohort, 247 people with diabetes developed foot wounds, and 30 had osteomyelitis defined by bone culture. A negative probe-to-bone result was strongly reassuring in that population, but a positive result did not always mean infection. The difference illustrates how a test’s meaning depends on how likely disease was before testing. Its published accuracy should therefore be interpreted alongside the wound, examination, and other investigations, rather than treated as a stand-alone answer. This is a clinician-performed examination; do not insert a probe into a wound yourself. [10]

Why a Bone Biopsy Is Sometimes Needed

A bone biopsy can supply tissue for culture and microscopic examination, but the route to a useful sample depends on the situation. The Society of Academic Bone Radiologists’ 2024 consensus addresses chronic nonspinal osteomyelitis in adults. It considers MRI findings, wounds and whether surgery is already necessary before recommending an image-guided biopsy. Some patients instead have samples collected during an operation. Recommendations about pausing antibiotics are clinician-led decisions for selected stable patients; they must never delay treatment of sepsis or deterioration. Do not stop medicine to improve a test. The evidence for biopsy strategy and antibiotic timing remains imperfect. [11]

Surface bacteria may tell another story

A wound swab can identify organisms living at the surface without reliably identifying those inside infected bone. In Senneville and colleagues’ diabetic-foot study, bone cultures and paired ulcer swabs matched exactly in only 12 of 69 patients. This helps explain why the place and method of sampling influence interpretation. The study included selected patients with positive bone cultures who had been off antibiotics, so its percentages are not universal. It also examined superficial swabs, which should not be confused with the deeper ulcer-bed biopsies evaluated in newer research. [12]

A negative biopsy can leave uncertainty

Obtaining a sample does not guarantee that a laboratory will identify the organism. Maamari and colleagues reviewed 209 patients investigated for native vertebral osteomyelitis. Initial image-guided biopsies produced a microbiological diagnosis in just over half; including repeat procedures increased the yield. Successful fluid aspiration was associated with better recovery of organisms, while previous antibiotic exposure was associated with lower yield. These observations help explain why a negative culture may lead to reassessment or additional sampling. They concern diagnostic yield in a retrospective study, rather than proving that one preparation strategy is always safest. [13]

New evidence on biopsy-guided treatment

The completed BeBoP trial adds a newer perspective to diabetic-foot sampling. Eighty-four adults received treatment guided by either bone-biopsy cultures or cultures from an ulcer-bed biopsy. The study did not demonstrate better remission with the bone-guided strategy at twelve months. This does not mean all samples are interchangeable: the comparison involved deeper biopsies, not ordinary surface swabs, and the estimates were uncertain. It also tested treatment outcomes rather than whether bone infection was present. The distinction helps explain how bone sampling can remain diagnostically valuable without guaranteeing better outcomes in every treatment pathway. [14]

Different scans answer different questions

A prospective study by Kouijzer and colleagues compared MRI with FDG-PET/CT in 32 adults with suspected vertebral osteomyelitis. Both methods detected the confirmed infections in this small group, but their strengths differed: MRI better identified small epidural abscesses, while PET/CT could reveal infection elsewhere in the body. The results illustrate why imaging is chosen for a clinical question, such as defining a local complication or looking for distant spread. The sample was too small to promise perfect accuracy, and findings from spinal infection should not be generalized to every bone or wound. [15]

Pressure ulcers create a different diagnostic problem

Bone changes beneath a longstanding pressure ulcer can be difficult to interpret. Brunel and colleagues investigated pelvic ulcers in 34 people with spinal cord injuries, comparing MRI with multiple bone samples examined for organisms and tissue changes. MRI detected most infections defined by the study, but frequently suggested infection when the combined biopsy criteria did not confirm it. This is a useful warning about applying a scan result without context. It does not undermine MRI’s role elsewhere; it shows that diagnostic performance can change substantially with the underlying wound and patient population. [16]

Treating Diabetes-Related Foot Osteomyelitis

The joint IWGDF/IDSA guideline is dated 2023 and addresses diabetes-related foot infection specifically. Treatment brings together infection management, wound care, pressure relief, circulation assessment and diabetes care. Severe infection, deep collections, extensive tissue damage or impaired circulation may require urgent surgical and vascular input. Selected forefoot osteomyelitis may sometimes be treated without surgery when there is no immediate drainage need, peripheral artery disease or exposed bone. Clinically uninfected ulcers should not receive antibiotics simply to promote healing. A positive wound culture alone cannot establish invasive infection. Decisions depend on the examination, depth, blood supply and reliable microbiological evidence. [17]

When surgery may be avoidable

Some diabetic-foot bone infections can be managed without immediately removing bone, but the evidence concerns selected patients. A small randomized trial by Lázaro-Martínez and colleagues found similar short-term healing outcomes with antibiotics alone and conservative surgery. Four patients initially assigned antibiotics later needed an operation. Participants had neuropathic forefoot ulcers without poor arterial circulation or necrotizing soft-tissue infection, and several other high-risk conditions were excluded. Follow-up after healing was also brief. The useful lesson is that treatment choice depends on the foot’s condition; the study does not make surgery unnecessary across diabetic-foot osteomyelitis. [18]

When Hardware and Bone Healing Interact

Fracture-related infection has an extra challenge: fixation may still be needed for the bone to unite. International consensus guidance combines specialist infection care with removal of nonviable tissue, representative deep samples, stable fixation and adequate soft-tissue coverage. An implant may be retained, exchanged or removed depending on healing, stability and the infection. Bacteria attached to implants can form biofilms, making eradication harder. These decisions differ from those for a permanent joint replacement or infection in bone without hardware. The recommendations include expert consensus because trials leave important gaps. Successful source control addresses the infected tissues and the mechanical problem together. [19]

Recovery after a fracture has two goals

When infection follows a fracture, success involves controlling infection and allowing the broken bone to heal. McNally and colleagues followed 433 surgically treated fracture-related infections across centers. Infection was eradicated in about 86%, and a similar proportion of fractures that were initially unhealed subsequently united. The study also examined stabilization, soft-tissue reconstruction, and local antibiotic use. Because treatments were selected clinically, comparisons cannot prove that one technique caused better results. The broader lesson is that recovery depends on the whole reconstruction plan, rather than the antibiotic choice or time since injury alone. [20]

Why source control matters

Antibiotics work within a physical environment, and damaged infected bone can complicate recovery. In a prospective series of 50 patients with chronic osteomyelitis, Simpson and colleagues found that recurrence differed according to the extent of surgical removal and the patient’s underlying health. All groups also received antibiotics. The study helps explain why controlling infection sometimes requires addressing the infected tissue itself. Its historical, nonrandomized design cannot define the right operation or a universal clearance margin today. Surgeons must balance infection control with preserving useful bone, maintaining stability, and making reconstruction possible. [21]

What OVIVA Says About Oral Treatment

Intravenous treatment is not automatically more effective for every bone infection. OVIVA randomized 1,054 adults with selected bone or joint infections to specialist-chosen oral or intravenous antibiotics during the initial treatment phase. Oral treatment met the trial’s noninferiority criterion for treatment failure at one year, with fewer catheter complications. This supports an appropriate oral option when the organism, medicine, absorption and clinical circumstances allow it. The trial excluded recent Staphylococcus aureus bloodstream infection, endocarditis and other situations requiring intravenous therapy. It did not establish equivalence for every infection subgroup, children or uncontrolled sepsis, and it does not support switching medicines independently. [22]

Why avoiding a catheter can matter

The practical benefit of oral treatment includes avoiding complications from the delivery system. Keren and colleagues studied 2,060 children discharged after treatment for acute osteomyelitis. After statistical adjustment, children receiving oral antibiotics did not have more treatment failures than those receiving antibiotics through a peripherally inserted central catheter, or PICC. Among children with PICCs, 15% experienced a catheter complication requiring an emergency visit, hospitalization, or both. Because clinicians selected treatment rather than assigning it randomly, the findings need context. They support carefully chosen oral options for suitable children after hospital care. [23]

Newer evidence on initial treatment

A Danish randomized trial published in 2024 examined whether selected children could begin treatment orally. It enrolled children and adolescents with suspected uncomplicated bone or joint infection across 18 hospitals. Among confirmed cases assessed at six months, neither treatment group had lasting functional problems, and initial oral treatment met the trial’s statistical standard for noninferiority. The boundaries matter: severe illness, urgent surgical needs, major soft-tissue involvement, implants, and important accompanying conditions were excluded. The study broadens the evidence for specialist-selected oral treatment, while leaving questions about more complicated infections unanswered. [24]

Why pediatric study populations matter

Peltola and colleagues tested shorter and longer antibiotic courses in 131 children with culture-confirmed infection that had reached bone through the bloodstream. Outcomes were reassuring in both groups, with only one mild lasting problem in each. However, most infections involved Staphylococcus aureus, and every strain of that organism was susceptible to methicillin. Treatment decisions also followed predefined measures of clinical recovery and inflammation. These details explain why a successful pediatric trial cannot supply a universal stopping rule. Resistant organisms, different infection routes, and complicated disease may present a different clinical problem. [25]

Longer treatment has its own costs

Tone and colleagues compared two antibiotic-course lengths in 40 people whose diabetic-foot osteomyelitis was managed without bone surgery. Remission rates did not differ significantly, while gastrointestinal side effects were more frequent with the longer course. Remission required sustained wound healing, no recurrent infection, and no subsequent bone removal or amputation during extended follow-up. The study supports questioning unnecessary antibiotic exposure, but its small size leaves uncertainty about modest differences between strategies. It cannot determine an individual patient’s course length, especially when surgery, circulation, or infection severity creates a different situation. [26]

What a pilot trial can establish

Gariani and colleagues explored shorter antibiotic treatment after debridement for diabetic-foot osteomyelitis. Among 93 participants, remission and adverse-event results were similar between groups. A pilot trial, however, is an early test rather than a final answer for every patient. Its statistical margin allowed a relatively large difference. Minimum follow-up after treatment was two months, although many participants were followed longer. The study included different surgical pathways, including partial amputations, so its findings require careful interpretation when the amount of infected bone remaining or the surgical approach differs. [27]

Spinal evidence has its own boundaries

The DTS trial tested two treatment lengths in adults with microbiologically confirmed pyogenic vertebral osteomyelitis. An independent committee judged approximately 91% of patients cured at one year in each group, and the shorter strategy met the trial’s noninferiority criterion. This is stronger evidence than simply observing similar outcomes in routine practice. Even so, it answers a question about a defined spinal-infection population. It does not set one duration for all bone infections or prove identical effects in every subgroup. The organism, anatomy, complications, and response still determine how clinicians apply the findings. [28]

Monitoring Continues Outside Hospital

Home treatment still requires an organized clinical service. The 2026 UK outpatient antimicrobial recommendations emphasize monitoring response, medicine side effects, drug interactions and intravenous-line problems. Blood tests may check blood counts, kidney or liver function, and sometimes medicine levels. The service should provide a clear route to urgent advice and review. Complex oral treatment also needs a monitoring plan; avoiding a catheter does not remove medication risks. Before discharge, patients should understand who reviews results and whom to contact if symptoms change. The treating team determines adjustments, including when treatment is complete, rather than a calendar or improvement alone. [29]

Why scans can lag behind recovery

An abnormal follow-up scan does not automatically mean that treatment has failed. Kowalski and colleagues reviewed serial MRI examinations in 33 adults treated for spinal infection. Soft-tissue inflammation often improved while changes in bone or discs persisted or appeared worse. No single imaging finding reliably matched the patient’s clinical status. The study was small and retrospective, but it illustrates why clinicians interpret scans alongside symptoms, examination, and laboratory trends. Persistent abnormalities deserve context; conversely, new symptoms or deterioration should not be dismissed simply because some scan changes can outlast the infection. [30]

Practical support during osteomyelitis care

Care planning questions
Topic	What to clarify
Coordination	Who is responsible for the next step?
Results	When should I hear back, and whom should I contact?
Medicines	Who can explain an unfamiliar or conflicting instruction?
Home arrangements	What support needs to be confirmed before discharge?

Prepare questions and track results

Before an osteomyelitis appointment, write down the concerns you most want answered and any changes since the previous visit. Bring relevant treatment history rather than relying on memory. If a sample has been taken for culture, ask which result is still pending, who will explain it, and how you will hear back. [31]

Record the contact route and the time the team expects to update you. Ask what the result might change about the agreed plan, without trying to interpret laboratory wording yourself. If the expected update does not arrive, contact the service that ordered the test and request clarification. [31]

Understand the agreed plan

A useful explanation connects the problem being addressed, the next action, and the reason that action matters. Ask the clinician to explain those three parts in everyday language. It is reasonable to return to a point that remains confusing, even if it has already been discussed during the visit. [35]

For example, ask how the next appointment fits into the overall plan and what question it should answer. Write the explanation in words you understand and identify anything that still needs clarification. These practical communication habits support participation in care; they are not treatments for the bone infection itself. [35]

Explain what matters to you

Tell the treating team which practical concerns could affect a proposed plan. These may include caring responsibilities, difficult transport, work commitments, or anxiety about managing care away from hospital. Mentioning a barrier gives the team a chance to help address it. Ask which decisions need to be made now and which allow further discussion. [36]

When options are offered, ask about their intended benefits, possible harms, uncertainties, and demands on daily life. Explain what you hope to achieve and what worries you most. Agree how much support you want with decisions, and ask to revisit information that is too much to absorb at once. [36]

Know who coordinates each step

When several services are involved, ask who has responsibility for the overall plan and who handles each immediate task. A referral should come with an explanation of why it is needed, what happens next, and whom to contact with concerns. Keep service names, telephone numbers, and appointment details together. [32]

If two sets of instructions appear different, ask the responsible clinicians to reconcile them. Explain exactly which documents or conversations caused the confusion. Before a transfer of care, check that the receiving service has the information it needs and that you know whom to contact while waiting for the next appointment. [32]

Make discharge arrangements concrete

Before leaving hospital, ask for the discharge information and check how it will reach the clinicians providing ongoing care. The summary should help explain what happened, the treatment received, medicines, and planned follow-up. Ask staff to clarify arrangements that have been discussed but not yet confirmed, including who will contact you next. [34]

Describe any practical difficulty carrying out the plan at home so that staff can address it before you leave. Obtain the treating team’s specific instructions about activity, weight bearing, offloading, and any device. Ask which service provides any required training or support; a general article cannot supply those individual instructions. [34]

Keep medicine information consistent

Bring an up-to-date list of prescribed medicines, nonprescription products, supplements, and known medicine allergies to discussions with the doctor or pharmacist. Include products used occasionally. Explain how you actually take each medicine, especially when this differs from the directions, and describe any difficulty understanding labels or fitting the prescribed schedule into daily life. [33]

Ask the pharmacist to explain unfamiliar instructions and resolve an unexpected difference between a new supply and the recorded prescription. Keep written information with the current list so another clinician can review it. Decisions about changing an antibiotic, its schedule, or its duration belong with the prescribing team. [33]

Ask for accessible communication

Tell the service before a visit if a hearing, vision, or speech disability affects communication. Explain what works for you, such as captions, a sign language interpreter, large print, or a document that works with a screen reader. The appropriate support depends on the person and the complexity of the discussion. [37]

Check that the same communication method will be available when important results or instructions are discussed later. A familiar relative may provide reassurance, but should not automatically be expected to interpret a complex consultation. Ask the service how it will arrange effective communication and how to report an access problem. [37]

Choose who joins care discussions

Decide whom you would like involved and what information you are comfortable sharing with them. One person may help arrange appointments while another accompanies you to discussions. Tell the clinical team about these different roles, rather than assuming that everyone needs the same details or that relatives should make decisions for you. [38]

In US settings covered by HIPAA, relevant information may be shared with people involved in care when the applicable conditions are met, including agreement or lack of objection in ordinary discussions. Ask the provider how to record your preferences. You can also request part of an appointment without a companion present. [38]

Share household work realistically

A short conversation among the people helping at home can turn general offers into realistic commitments. Start with the person receiving care and their preferences. Discuss ordinary tasks such as shopping, meals, transport arrangements, collecting paperwork, or keeping track of appointments. Ask what each helper can actually manage alongside their other responsibilities. [39]

Record the tasks people agree to take on and choose a time to review the arrangement. Someone living farther away may still help with telephone calls or scheduling. If disagreements make planning difficult, ask whether a social worker or another suitable facilitator can help everyone discuss needs and expectations. [39]

Prepare backup help

Consider what would happen if the usual helper became ill or could not arrive. Agree whom to call and check that those people are willing to be named as backup contacts. Keep essential contact details, current care arrangements, allergies, and the location of the agreed care information together in a place authorized helpers can find. [40]

Discuss the plan with the person receiving support and review it when arrangements change. Include the services already involved so a substitute helper knows where to seek guidance. Backup planning should identify how to obtain professional help; it should not assume that a relative can perform unfamiliar clinical tasks. [40]

Discuss work without guessing timelines

Prepare for a conversation with the employer about absence, appointments, and the support needed for a possible return. Describe the demands of the job to the treating team so its advice can inform that discussion. Ask whether occupational health input, adjusted duties, changed hours, or a phased return should be considered for your situation. [41]

Agree what colleagues need to know and what should remain confidential. Record the arrangements and their review date. Acas guidance supports this planning conversation, but it does not set an osteomyelitis recovery timetable. Readiness for particular tasks requires advice relevant to the individual. [41]

Check travel plans early

Before booking air travel during ongoing care, discuss the itinerary with the treating team and ask the airline about its medical clearance process. Explain any assistance or medical equipment needs early enough for the airline to assess them. Permission to travel still leaves practical arrangements to confirm. [42]

Check the insurance policy’s requirements for declaring medical conditions and changes in health. Ask how planned appointments and treatment would be maintained while away, and whom to contact if plans change. Travel permission, equipment arrangements, and any activity limits require individual advice rather than assumptions drawn from another person’s experience. [42]

Raise cost problems early

If costs are making care difficult, explain the problem to the service’s financial counselor or billing staff and ask about available assistance. Different providers may run separate programs, so one answer may not cover every bill. Note contacts, requested documents, deadlines, and arrangements discussed. [43]

Include practical costs such as transport or help at home when describing the difficulty. Patient Advocate Foundation guidance points to assistance resources for eligible people as well as conversations about affordable payment arrangements. Check eligibility and terms before relying on any program, and tell the clinical team if a cost barrier threatens an appointment or treatment. [43]

Find accessible follow-up support

If you lack a regular local clinician, ask the treating service to help identify where ongoing general care can be obtained. In the United States, HRSA-supported community health centers are an option to investigate, including for people without health insurance. Charges follow the center’s sliding fee arrangements; ask about services and application requirements. [44]

When making an inquiry, explain the follow-up requested by the hospital and ask whether the center can provide it or coordinate with the specialist. Check appointment availability, transport, and how records will be received. A local clinic should not be assumed to provide every specialist investigation or treatment. [44]

Request and organize your records

Ask the provider how to obtain the reports needed for a forthcoming consultation. Be specific about the documents and dates, such as a discharge summary or a particular investigation report, and explain any accessible-format requirement. Keep the request and contact details so that you can follow up accurately. [45]

In the United Kingdom, the ICO explains how people can request copies of their personal information. A representative needs appropriate permission. Once records arrive, keep them organized by date and ask a clinician about unfamiliar terms. If another service needs the records urgently, ask the clinical teams to arrange that transfer. [45]

Frequently asked questions

Can a normal X-ray exclude it?

Not early on. If suspicion remains, clinicians may use MRI or other investigations suited to the affected site. [3]

Does everyone need intravenous antibiotics?

Selected adults can receive specialist-chosen oral treatment. Suitability depends on the infection, organism, medicine and clinical stability. [22]

Does every bone infection need surgery?

Surgery depends on infected tissue, collections, stability and implants. A specialist team decides what source control is necessary. [19]

Should a sick child wait for biopsy?

An ill child or rapidly progressing infection needs immediate treatment. Sampling must not delay urgent care. [7]

Can antibiotics heal an uninfected ulcer?

They are not recommended solely to help an uninfected ulcer heal. Wound care, pressure relief and circulation assessment remain important. [17]

Can treatment stop when pain improves?

Follow the treating team’s plan. Improvement alone does not determine completion; symptoms, treatment response and safety monitoring guide review. [29]